GT200000138CA - Gen de steptomyces avermitilis que dirige la relacion de avermectinas b1:b2 (solicitud fraccionaria no.3, derivada de lapatente pi-2000-0138) - Google Patents

Gen de steptomyces avermitilis que dirige la relacion de avermectinas b1:b2 (solicitud fraccionaria no.3, derivada de lapatente pi-2000-0138)

Info

Publication number
GT200000138CA
GT200000138CA GT200000138CM GT200000138M GT200000138CA GT 200000138C A GT200000138C A GT 200000138CA GT 200000138C M GT200000138C M GT 200000138CM GT 200000138 M GT200000138 M GT 200000138M GT 200000138C A GT200000138C A GT 200000138CA
Authority
GT
Guatemala
Prior art keywords
avermitilis
lapatent
avermectines
fractionary
steptomyces
Prior art date
Application number
GT200000138CM
Other languages
English (en)
Spanish (es)
Inventor
Kim Jonelle Stutzman-Engwall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200000138CA publication Critical patent/GT200000138CA/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GT200000138CM 1999-08-12 2000-08-11 Gen de steptomyces avermitilis que dirige la relacion de avermectinas b1:b2 (solicitud fraccionaria no.3, derivada de lapatente pi-2000-0138) GT200000138CA (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/372,934 US6248579B1 (en) 1998-02-13 1999-08-12 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins

Publications (1)

Publication Number Publication Date
GT200000138CA true GT200000138CA (es) 2002-02-02

Family

ID=23470234

Family Applications (2)

Application Number Title Priority Date Filing Date
GT200000138CM GT200000138CA (es) 1999-08-12 2000-08-11 Gen de steptomyces avermitilis que dirige la relacion de avermectinas b1:b2 (solicitud fraccionaria no.3, derivada de lapatente pi-2000-0138)
GT200000138A GT200000138A (es) 1999-08-12 2000-08-11 Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2 : b1 (1).

Family Applications After (1)

Application Number Title Priority Date Filing Date
GT200000138A GT200000138A (es) 1999-08-12 2000-08-11 Gen de streptomyces avermitilis que dirige la relacion de avermectinas b2 : b1 (1).

Country Status (37)

Country Link
US (8) US6248579B1 (no)
EP (1) EP1200605B1 (no)
JP (2) JP3688640B2 (no)
KR (1) KR100486006B1 (no)
CN (1) CN1186447C (no)
AP (2) AP2002002419A0 (no)
AR (1) AR021450A1 (no)
AT (1) ATE283363T1 (no)
AU (1) AU779756B2 (no)
BG (1) BG106478A (no)
BR (1) BR0013093A (no)
CA (1) CA2381427A1 (no)
CO (1) CO5290296A1 (no)
CZ (1) CZ2002297A3 (no)
DE (1) DE60016231T2 (no)
EA (1) EA004569B1 (no)
ES (1) ES2231214T3 (no)
GT (2) GT200000138CA (no)
HK (1) HK1046536B (no)
HR (1) HRP20020131A2 (no)
HU (1) HUP0202517A2 (no)
IL (1) IL147562A0 (no)
IS (1) IS6249A (no)
MA (1) MA26811A1 (no)
MX (1) MXPA02001514A (no)
NO (1) NO20020665L (no)
OA (1) OA11997A (no)
PA (1) PA8499201A1 (no)
PE (1) PE20010697A1 (no)
PL (1) PL353770A1 (no)
PT (1) PT1200605E (no)
SK (1) SK1382002A3 (no)
TN (1) TNSN00170A1 (no)
UY (1) UY26287A1 (no)
WO (1) WO2001012822A1 (no)
YU (1) YU8402A (no)
ZA (1) ZA200201071B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1200606B1 (en) * 1999-08-12 2006-10-04 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
PL371746A1 (en) 2002-02-05 2005-06-27 Bristol-Myers Squibb Company N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
ATE530645T1 (de) * 2002-02-12 2011-11-15 Pfizer Prod Inc Streptomyces avermitilis gen zur regulierung des verhältnisses der b2:b1 avermectine
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US8440609B2 (en) * 2003-01-31 2013-05-14 Gerd Wallukat Peptides against autoantibodies causing intolerance to cold and use thereof
KR100759130B1 (ko) 2005-02-12 2007-09-19 휴메드 주식회사 항 인테그린 항체 코팅스텐트 및 그의 제조방법
CN106148216B (zh) 2015-03-27 2019-06-04 浙江海正药业股份有限公司 一种链霉菌及其生产米尔贝霉素a3的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
ES2054822T3 (es) 1987-10-23 1994-08-16 Pfizer Procedimiento para la produccion de agliconas de avermectinas y sus cultivos.
ES2079436T3 (es) 1989-03-31 1996-01-16 Merck & Co Inc Clonacion de genes de streptomyces avermitilis para biosintesis de avermectinas y procedimientos para su uso.
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
DK0711349T3 (da) 1993-07-30 2003-11-24 Pfizer Gener, der koder for forgrenet alfaketosyredehydrogenasekompleks fra Streptomyces avermitilis
RO115884B1 (ro) * 1993-10-05 2000-07-28 Pfizer Derivati de doramectin, procedeu de preparare, metoda de tratare
FI942725A (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
EP1053335A1 (en) * 1998-02-13 2000-11-22 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Also Published As

Publication number Publication date
HRP20020131A2 (en) 2003-12-31
PL353770A1 (en) 2003-12-01
YU8402A (sh) 2006-03-03
AP2002002417A0 (en) 2002-03-31
US6511841B2 (en) 2003-01-28
KR20020022809A (ko) 2002-03-27
DE60016231T2 (de) 2005-12-08
DE60016231D1 (de) 2004-12-30
AU5702100A (en) 2001-03-13
CA2381427A1 (en) 2001-02-22
GT200000138A (es) 2002-02-02
US20010024818A1 (en) 2001-09-27
NO20020665D0 (no) 2002-02-11
CO5290296A1 (es) 2003-06-27
EA004569B1 (ru) 2004-06-24
HUP0202517A2 (hu) 2002-11-28
US7259241B2 (en) 2007-08-21
US6248579B1 (en) 2001-06-19
PA8499201A1 (es) 2001-12-14
WO2001012822A1 (en) 2001-02-22
US20030134313A1 (en) 2003-07-17
OA11997A (en) 2006-04-18
AR021450A1 (es) 2002-07-17
MA26811A1 (fr) 2004-12-20
US20030129636A1 (en) 2003-07-10
ES2231214T3 (es) 2005-05-16
HK1046536B (zh) 2005-05-13
AU779756B2 (en) 2005-02-10
CN1370239A (zh) 2002-09-18
US6509159B2 (en) 2003-01-21
CZ2002297A3 (cs) 2002-08-14
SK1382002A3 (en) 2002-11-06
ATE283363T1 (de) 2004-12-15
EP1200605A1 (en) 2002-05-02
PT1200605E (pt) 2005-04-29
NO20020665L (no) 2002-02-11
AP2002002419A0 (en) 2002-03-31
JP3688640B2 (ja) 2005-08-31
EA200200057A1 (ru) 2002-06-27
JP2005198658A (ja) 2005-07-28
US20030124607A1 (en) 2003-07-03
PE20010697A1 (es) 2001-07-05
KR100486006B1 (ko) 2005-05-03
US6833263B2 (en) 2004-12-21
BG106478A (bg) 2004-02-27
JP2003507018A (ja) 2003-02-25
US7029887B2 (en) 2006-04-18
BR0013093A (pt) 2002-08-13
CN1186447C (zh) 2005-01-26
IL147562A0 (en) 2002-08-14
IS6249A (is) 2002-01-25
US20010016350A1 (en) 2001-08-23
TNSN00170A1 (fr) 2005-11-10
EP1200605B1 (en) 2004-11-24
US20050196777A1 (en) 2005-09-08
MXPA02001514A (es) 2002-07-02
ZA200201071B (en) 2003-06-25
HK1046536A1 (en) 2003-01-17
US20030129635A1 (en) 2003-07-10
UY26287A1 (es) 2001-03-16

Similar Documents

Publication Publication Date Title
HUP0202639A2 (en) Immunostimulatory nucleic acids
Staehelin The primary structure of transfer ribonucleic acid
BR9712878A (pt) Variante de enzima subtilase, processos para a identificação de uma variante de protease apresentando estabilidade autoproteolìtica e paraq a produção de uma enzima subtilase mutante e de uma variante de subtilase, sequência de dna, vetor, célula hospedeira microbiana, composição e uso de uma variante de subtilase.
DK1337648T3 (da) Ny cyclodextrin-glucanotransferase (CGTase) fra Bacillus agaradherens (DSM 9948) samt vaske- og rengöringsmidler med denne nye cyclodextrin-glucanotransferase
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
EP1700915A3 (en) Enzymatic DNA molecules
BR9811248B1 (pt) variante de enzima subtilase derivada de uma subtilase originária selecionada a partir do sub-grupo i-s1 ou do sub-grupo i-s2, dita variante tendo melhorado desempenho de lavagem em detergentes em comparação com a subtilase originária, sequência de dna isolada, vetor de expressão, célula hospedeira microbiana, processo para produzir uma variante, composição, uso de uma variante de subtilase.
CA2079454A1 (en) Steroid 5.alpha.-reductases
BR0003943A (pt) Sequências de nucleotìdeo que codificam para o gene thre e processo para a produção enzimática de l-treonina usando bactérias corineforma
WO2003089606A3 (en) Thermostable dna polymerases and methods of making same
GT200000138CA (es) Gen de steptomyces avermitilis que dirige la relacion de avermectinas b1:b2 (solicitud fraccionaria no.3, derivada de lapatente pi-2000-0138)
CY1105778T1 (el) Γονιδιο του streptomyces avermitilis που κατευθυνει την αναλογια των αβepμεκτινων β2:β1
AP9901463A0 (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins.
CY1112491T1 (el) Γονιδιο streptomyces avermitilis που ελεγχει την αναλογια αβερμεκτινων β2:β1
BR0110128A (pt) Mutante de bactéria láctica superprodutora de exopolissacarìdeos, utilização do mesmo e ácido nucleico codificando uma alfa-fosfoglucomutase
HUP0400150A2 (en) Saponin-digesting enzymes, genes thereof and soyasapogenol b mass production system
ES2164545A1 (es) Enzimas con actividad beta-(1,6)-endoglucanasa.
UA28735A (uk) Піногасник для процесу культивування хлібопекарських дріжджів